Clinical Trials Sponsored by Tianjin Medical University Second Hospital

Total 11307 results

Tianjin Medical University Second Hospital

Recruiting

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma, Advanced

China
Tianjin Medical University Second Hospital

Recruiting

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Solid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene Translocation

China
Tianjin Medical University Second Hospital

Recruiting

Tislelizumab Plus Lenvatinib in Stage III-IV RCC (TILUR)

Advanced Kidney Cancer

China
Tianjin Medical University Second Hospital

Recruiting

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center Study

High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Muscle Invasive Bladder Cancer Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer (SAARCC)

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Non-Muscle Invasive Bladder Urothelial Carcinoma | High-Risk

China
Tianjin Medical University Second Hospital

Not yet recruiting

Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer

Lung Neoplasms | Oligometastasis
Tianjin Medical University Second Hospital

Completed

Study on the Influencing Factors of Electroencephalogram Parameters Under Anesthesia

EEC

China
Tianjin Medical University Second Hospital

Unknown

Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing

Solid Tumor, Adult

China
Tianjin Medical University Second Hospital

Recruiting

Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma (PANDORA)

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Selective Treatment According to Molecular Subtype of Prostate Cancer (STAMP)

Castration-resistant Prostate Cancer | Prostate Cancer Metastatic

China
Tianjin Medical University Second Hospital

Active, not recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma

Urothelial Carcinoma | Muscle Invasive Bladder Cancer

China
Tianjin Medical University Second Hospital

Unknown

A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Small Cell Lung Cancer Extensive Stage

China
Tianjin Medical University Second Hospital

Unknown

Advanced Refractory Solid Tumors With TP53 Mutations Register Study

Solid Tumor, Adult

China
Tianjin Medical University Second Hospital

Recruiting

MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors

Refractory Solid Tumors | Next Generation Sequencing

China
Tianjin Medical University Second Hospital

Recruiting

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Solid Tumor | EGFR Amplification

China
Tianjin Medical University Second Hospital

Recruiting

Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer

Bladder Cancer

China
Tianjin Medical University Second Hospital

Recruiting

DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

Solid Tumor | Individuation

China
Tianjin Medical University Second Hospital

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Neoadjuvant Immunotherapy

China
Tianjin Medical University Second Hospital

Recruiting

Pembrolizumab Plus Lenvatinib in Stage III-IV RCC

Advanced Kidney Cancer

China
Tianjin Medical University Second Hospital

Recruiting

A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Urogenital Neoplasms | Urothelial Carcinoma | Antineoplastic Agents | Gemcitabine | Cisplatin | Anlotinib | Carboplatin

China
Tianjin Medical University Second Hospital

Unknown

Personalized Mini-PDX for Metastatic CRPC

Prostate Cancer

China
Tianjin Medical University Second Hospital

Unknown

Predictive Nomogram of CRPC (CRPC-PN)

Metastatic Cancer | Castration-resistant Prostate Cancer

China
Tianjin Medical University Cancer Institute and...
Tianjin Medical University General Hospital; Tianjin Medical University Second...

Not yet recruiting

Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer

Supraglottic Cancer

China
Tianjin Medical University Cancer Institute and...
Tianjin Medical University General Hospital; Tianjin Medical University Second...

Not yet recruiting

Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer

Hypopharyngeal Carcinoma

China
Tianjin Second People's Hospital

Not yet recruiting

Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis (CABER)

Gastroesophageal Varices | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C

China
Tianjin Medical University Second Hospital
Tianjin Medical University General Hospital; Tianjin First Central Hospital; The...

Not yet recruiting

Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

Prostate Cancer

China
Beijing Tiantan Hospital
Tianjin Medical University General Hospital

Recruiting

Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination (STAND)

Nervous System Diseases | Immune System Diseases | Autoimmune Diseases of the Nervous System | Autoimmune Diseases | Diagnostic Self Evaluation | NMO Spectrum Disorder | NMDA-R Encephalitis

China
Tianjin Medical University
Tianjin Hospital

Recruiting

Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Emergency Laparotomy (ERAS)

Acute Abdomen | Abdominal Trauma | Emergency Surgery

China
Tianjin Medical University Second Hospital
CSPC Pharmaceutical Group Limited

Unknown

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Muscle Invasive Bladder Cancer

China
Tianjin Medical University Second Hospital
The Second Hospital of Hebei Medical University; Tianjin Medical University... and other collaborators

Completed

Tissue Predictors of Abiraterone Benefit

Metastatic Castration-resistant Prostate Cancer

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Herombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Herombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Chemotherapy-induced Thrombocytopenia | Avatrombopag

China
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaborators

Recruiting

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Eltrombopag | Chemotherapy-induced Thrombocytopenia

China
Tianjin Medical University
Tianjin Medical University General Hospital

Recruiting

Cohort Study of Blood Biomarkers for TES

Chronic Traumatic Encephalopathy | Traumatic Encephalopathy, Chronic | Traumatic; Encephalopathy, Postcontusional

China
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Solid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein Overexpression

China
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Treatment of Carrying TP53 Harmful Mutations

Advanced Cancer

China
Beijing Tiantan Hospital
Beijing Friendship Hospital; The Second Hospital of Hebei Medical University; Xuanwu Hospital, Beijing and other collaborators

Unknown

The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia (CBROAUNACCI)

Intracranial Aneurysm | Cerebral Ischemia

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Tianjin Medical University Second Hospital; The Second... and other collaborators

Recruiting

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Tianjin Medical University Second Hospital; The Second... and other collaborators

Recruiting

Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Tianjin Medical University Cancer Institute and...
Tianjin Medical University General Hospital; Tianjin Chest Hospital

Completed

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

Delirium | Analgesia | NSCLC | Immunotherapy

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital; Tianjin Medical University General Hospital

Unknown

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

Malignant Gliomas

China
Peking Union Medical College Hospital
The Second Hospital of Hebei Medical University; Tianjin Medical University...

Recruiting

Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis

Autoimmune Pancreatitis

China
Tianjin Medical University General Hospital
Tianjin Medical University Cancer Institute and Hospital

Not yet recruiting

Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
Tianjin Medical University General Hospital

Recruiting

Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety

Sleep Disturbance

China
Tianjin Medical University General Hospital

Not yet recruiting

Gastrointestinal Decompression in Stroke (EAGER-ASSIST)

Stroke | Pulmonary Infection | Stomach Acidity | Gastrointestinal Decompression
Tianjin Medical University General Hospital

Recruiting

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Sleep Disturbance

China

Clinical Trials Sponsored by Tianjin Medical University Second Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations